List view / Grid view

Psoriasis (PsO)



Microneedle patch with precise vancomycin drug dose against MRSA skin infections

5 January 2022 | By ,

Effective vancomycin concentrations can be delivered locally to methicillin-resistant Staphylococcus aureus (MRSA)-infected sites of the skin with the use of miniaturised needles. This presents opportunities for targeted delivery of medication for focal skin diseases. Here, Georgios A Sotiriou and Liv Eidsmo of the Karolinska Institutet discuss some of them.


Technologies and tactics for accelerating end-to-end biologic drug development

29 November 2021 | By

Creating new biologic drugs from early research is a complex process, but certain development methodologies and practices are proving to reach clinical and commercial goals faster. In this article, Seahee Kim from Samsung Biologics provides insight into how contract development and manufacturing organisations (CDMOs) are applying new and effective methodologies…


P is for Psoriasis

5 December 2016 | By Niamh Louise Marriott, Digital Editor

P is for Psoriasis - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research...